Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of topical GK664S (clobetasol propionate) for moderate-to-severe scalp seborrheic dermatitis
jRCT2080224184Phase 3Completed
- Sponsor
- Maruho Co., Ltd.
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of clobetasol in seborrheic dermatitis (SD) (2 arms), sponsored by Maruho Co., Ltd. Started Dec 2018; status: completed.
02
Drugs
clobetasol
03
Conditions
seborrheic dermatitis (SD)
Beyond the preview
Go deeper on jRCT2080224184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224184.